HC Wainwright Reiterates Buy Rating on Rigel Pharmaceuticals, Keeps $85 Target
HC Wainwright reiterated its Buy rating and $85.00 price target. The target implies 84.9% upside from the Oct. 16 close of $45.97.
HC Wainwright reiterated its Buy rating and $85.00 price target. The target implies 84.9% upside from the Oct. 16 close of $45.97.